Ligand validation:5WGK

AGJ: N-hydroxy-4-{[(2-hydroxyethyl)(phenylacetyl)amino]methyl}benzamide

AGJ is a Ligand Of Interest in 5WGK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WGK_AGJ_A_816	22%	17%	0.211	0.824	2.44	1.35	4	3	2	0	100%	0.3

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.